The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Carbidopa/Levodopa Fair-Med 25 mg/250 mg Tablets



Fairmed Healthcare GmbHPA1789/007/004

Main Information

Trade NameCarbidopa/Levodopa Fair-Med 25 mg/250 mg Tablets
Active SubstancesLevodopa
Carbidopa monohydrate
Dosage FormTablet
Licence HolderFairmed Healthcare GmbH
Licence NumberPA1789/007/004

Group Information

ATC CodeN04BA Dopa and dopa derivatives
N04BA02 levodopa and decarboxylase inhibitor

Status

License statusAuthorised
Licence Issued04/03/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back